Antigen-mediated growth control of hybridoma cells via a human artificial chromosome

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 2, 2007, Pages 206-212

  Kawahara, Masahiro ^a   Inoue, Toshiaki ^b   Ren, Xianying ^b   Sogo, Takahiro ^a   Yamada, Hidetoshi ^b   Katoh, Motonobu ^b   Ueda, Hiroshi ^a   Oshimura, Mitsuo ^b   Nagamune, Teruyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Antibody; Growth control; Human artificial chromosome; Mammalian cell; Receptor

Indexed keywords

ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6;

ANIMAL CELL; ANTIGEN MEDIATED GENETICALLY MODIFIED CELL AMPLIFICATION; ARTICLE; ARTIFICIAL CHROMOSOME; CELL GROWTH; CHEMICAL MODIFICATION; CHIMERA; CHO CELL; CHROMOSOME 21; CLONING VECTOR; CONTROLLED STUDY; DNA MODIFICATION; GENE AMPLIFICATION; GENE CONSTRUCT; GENE THERAPY; GENE TRANSFER; GROWTH REGULATION; HUMAN ARTIFICIAL CHROMOSOME; HYBRIDOMA CELL CULTURE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

ANIMALS; CELL DIVISION; CELL LINE; CHO CELLS; CHROMOSOMES, ARTIFICIAL, HUMAN; CRICETINAE; CRICETULUS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; HYBRIDOMAS; INTERLEUKIN-6; MICE; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

MAMMALIA;

EID: 33845714561     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.10.014     Document Type: Article

References (29)

1. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4635-4640
2. Wojchowski D.M., Gregory R.C., Miller C.P., Pandit A.K., and Pircher T.J. Signal transduction in the erythropoietin receptor system. Exp. Cell Res. 253 (1999) 143-156
3. Ohashi H., Maruyama K., Liu Y.C., and Yoshimura A. Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 158-162
4. May P., Gerhartz C., Heesel B., Welte T., Doppler W., Graeve L., Horn F., and Heinrich P.C. Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation. FEBS Lett. 394 (1996) 221-226
5. Takahashi T., Tanaka M., Ogasawara J., Suda T., Murakami H., and Nagata S. Swapping between Fas and granulocyte colony-stimulating factor receptor. J. Biol. Chem. 271 (1996) 17555-17560
6. Ueda H., Kawahara M., Aburatani T., Tsumoto K., Todokoro K., Suzuki E., Nishimura H., Schueler P.A., Winter G., Mahoney W.C., Kumagai I., and Nagamune T. Cell-growth control by monomeric antigen; the cell surface expression of lysozyme-specific Ig V-domains fused to truncated Epo receptor. J. Immunol. Methods 241 (2000) 159-170
7. Kawahara M., Ueda H., Tsumoto K., Kumagai I., Mahoney W., and Nagamune T. A growth signal with an artificially induced erythropoietin receptor-gp130 cytoplasmic domain heterodimer. J. Biochem. 130 (2001) 305-312
8. Kawahara M., Natsume A., Terada S., Kato K., Tsumoto K., Kumagai I., Miki M., Mahoney W., Ueda H., and Nagamune T. Replacing factor-dependency with that for lysozyme: affordable culture of IL-6-dependent hybridoma by transfecting artificial cell surface receptor. Biotechnol. Bioeng. 74 (2001) 416-423
9. Kawahara M., Ueda H., Tsumoto K., Kumagai I., Mahoney W., and Nagamune T. Selection of highly productive mammalian cells based on an inducible growth advantage using an antibody/receptor chimera. J. Biosci. Bioeng. 93 (2002) 399-404
10. Kawahara M., Kimura H., Ueda H., and Nagamune T. Selection of genetically modified cell population using hapten-specific antibody/receptor chimera. Biochem. Biophys. Res. Commun. 315 (2004) 132-138
11. Kawahara M., Ueda H., Morita S., Tsumoto K., Kumagai I., and Nagamune T. Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch. Nucleic Acids Res. 31 (2003) e32
12. Thomas C.E., Ehrhardt A., and Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev., Genet. 4 (2003) 346-358
13. Pravtcheva D.D., and Wise T.L. A postimplantation lethal mutation induced by transgene insertion on mouse chromosome 8. Genomics 30 (1995) 529-544
14. Dobie K.W., Lee M., Fantes J.A., Graham E., Clark A.J., Springbett A., Lathe R., and McClenaghan M. Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6659-6664
15. Clark A.J., Harold G., and Yull F.E. Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Nucleic Acids Res. 25 (1997) 1009-1014
16. Ramirez A., Milot E., Ponsa I., Marcos-Gutierrez C., Page A., Santos M., Jorcano J., and Vidal M. Sequence and chromosomal context effects on variegated expression of keratin 5/lacZ constructs in stratified epithelia of transgenic mice. Genetics 158 (2001) 341-350
17. Harrington J.J., Van Bokkelen G., Mays R.W., Gustashaw K., and Willard H.F. Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nat. Genet. 15 (1997) 345-355
18. Kuroiwa Y., Shinohara T., Notsu T., Tomizuka K., Yoshida H., Takeda S., Oshimura M., and Ishida I. Efficient modification of a human chromosome by telomere-directed truncation in high homologous recombination-proficient chicken DT40 cells. Nucleic Acids Res. 26 (1998) 3447-3448
19. Guiducci C., Ascenzioni F., Auriche C., Piccolella E., Guerrini A.M., and Donini P. Use of a human minichromosome as a cloning and expression vector for mammalian cells. Hum. Mol. Genet. 8 (1999) 1417-1424
20. Grimes B.R., Schindelhauer D., McGill N.I., Ross A., Ebersole T.A., and Cooke H.J. Stable gene expression from a mammalian artificial chromosome. EMBO Rep. 2 (2001) 910-914
21. Katoh M., Ayabe F., Norikane S., Okada T., Masumoto H., Horike S., Shirayoshi Y., and Oshimura M. Construction of a novel human artificial chromosome vector for gene delivery. Biochem. Biophys. Res. Commun. 321 (2004) 280-290
22. Ren X., Katoh M., Hoshiya H., Kurimasa A., Inoue T., Ayabe F., Shibata K., Toguchida J., and Oshimura M. A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells. Stem Cells 23 (2005) 1608-1616
23. Kakeda M., Hiratsuka M., Nagata K., Kuroiwa Y., Kakitani M., Katoh M., Oshimura M., and Tomizuka K. Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts. Gene Ther. 12 (2005) 852-856
24. Boer P.H., Potten H., Adra C.N., Jardine K., Mullhofer G., and McBurney M.W. Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles. Biochem. Genet. 28 (1990) 299-308
25. Pihkala P., Kawahara M., Ueda H., and Nagamune T. An antigen-mediated selection system for mammalian cells that produce glycosylated single-chain Fv. Biochem. Biophys. Res. Commun. 324 (2004) 1165-1172
26. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P.G., Rubira M.R., and Simpson R.J. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 9679-9683
27. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 (2000) 1063-1066
28. Kawahara M., Ogo Y., Ueda H., and Nagamune T. Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain. Protein Eng. Des. Sel. 17 (2004) 715-719
29. Yamada H., Kunisato A., Kawahara M., Tahimic C.G.T., Ren X., Ueda H., Nagamune T., Katoh M., Inoue T., Nishikawa M., and Oshimura M. Exogenous gene expression and growth regulation of hematopoietic cells via a novel human artificial chromosome. J. Hum. Genet. 51 (2006) 147-150